¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"density gradient sedimentation equilibrium"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sedimentation time
    ħ°­½Ã°£
  • sedimentation velocity
    ħÀü¼Óµµ, ħ°­¼Óµµ
  • Westergren sedimentation rate
    ¿þ½ºÅͱ׷»Ä§°­¼Óµµ
  • zeta sedimentation ratio
    Á¦Å¸Ä§°­ºñ
  • acid-base equilibrium
    »ê¿°±âÆòÇü
  • dynamic equilibrium
    µ¿¿ªÇÐÀûÆòÇü
  • equilibrium
    ÆòÇü
  • equilibrium constant
    ÆòÇü»ó¼ö
  • equilibrium curve
    ÆòÇü°î¼±
  • equilibrium dialysis
    ÆòÇüÅõ¼®
  • equilibrium phase
    ÆòÇü±â
  • equilibrium reaction
    ÆòÇü¹ÝÀÀ
  • false equilibrium
    °ÅÁþÆòÇü
  • genetic equilibrium
    À¯ÀüÀûÆòÇü
  • heterogeneous equilibrium
    ºÒ±ÕÀÏÆòÇü, ºÒ±ÕÁúÆòÇü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • reticular density
    ±×¹°À½¿µ, ¸ÁÀ½¿µ
  • proton density weighted image
    ¾çÀڹеµ°­Á¶¿µ»ó
  • high density lipoprotein
    °í¹ÐµµÁöÁú´Ü¹é
  • low density lipoprotein
    Àú¹ÐµµÁöÁú´Ü¹é
  • very low density lipoprotein
    ÃÊÀú¹ÐµµÁöÁú´Ü¹é
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sedimentation reaction
    ħÀü¹ÝÀÀ
  • Westergren sedimentation rate
    ¿þ½ºÅͱ׷»Ä§°­¼Óµµ
  • zeta sedimentation ratio
    Á¦Å¸Ä§°­ºñ
  • sedimentation
    ħÀü
  • sedimentation technique
    ħÀü¹ý
  • sedimentation time
    ħÀü½Ã°£
  • sedimentation velocity
    ħÀü¼Óµµ
  • acid-base equilibrium
    »ê¿°±âÆòÇü
  • charged particle equilibrium
    ÇÏÀüÀÔÀÚÆòÇü, Àü±âÀÔÀÚÆòÇü
  • colloid equilibrium
    ÄÝ·ÎÀ̵åÆòÇü
  • equilibrium constant
    ÆòÇü»ó¼ö
  • equilibrium curve
    ÆòÇü°î¼±
  • driven equilibrium Fourier transform sequence
    ÃßÁøÆòÇüǪ¸®¾îº¯È¯¿¬¼â
  • dynamic equilibrium
    µ¿ÀûÆòÇü
  • equilibrium diagram
    ÆòÇü»óŵµ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • LDL = low density lipoprotein
    Àú¹ÐµµÁö´Ü¹é(î¸ÚËÓøò·Ó±ÛÜ)
  • REM density
    ·½¹Ðµµ
  • VLDL => very low density lipoprotein
    ÃÊÀú¹ÐµµÁö ´Ü¹éÁú
  • amorphous density
    ¹«Á¤Çü ¹Ðµµ(ÙíïÒúþ ÚËÓø)
  • apparent density
    °Ñº¸±â ¹Ðµµ.
  • grain density
    ÀÔÀÚ<±×·¡ÀÎ>¹Ðµµ.
  • high electron density
    °íÀüÀڹеµ(ÍÔï³í­ÚËöô).
  • high-density lipoprotein
    °í¹ÐµµÁö¹æ´Ü¹é
  • incidence density
    ¹ß»ý ºóµµ
  • innervation density
    ½Å°æÁö¹è¹Ðµµ(¡­ÚËöô).
  • pixel density
    Çȼ¿ À½¿µ, È­¼Ò À½¿µ
  • population density
    Àα¸¹Ðµµ(ÊÙËÑ̬).
  • postsynaptic density
    ¿¬Á¢ÀÌÈÄÄ¡¹ÐÁú
  • presynaptic density
    ¿¬Á¢ÀÌÀüÄ¡¹ÐÁú
  • proton (spin) density
    ¾çÀÚ ¹Ðµµ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sedimentation method
    ħ°­¹ýÀÔµµÃøÁ¤(í£öôö´ïÒ).
  • sedimentation rate
    ħ°­·ü( ˽ëÒ).
  • sedimentation reaction
    ħ°­¹ÝÀÀ(¡­Úãëë).
  • sedimentation time
    ħ°­½Ã°£( ˽ãÁÊà).
  • sedimentation velocity
    ħ°­¼Óµµ( ˽ áÜöô).
  • zeta sedimentation ratio
    Á¦Å¸Ä§°­ºñ(À²)
  • acid-base balance=acid-base equilibrium
    »ê¿°±â ÆòÇü(¡­øÁû¬)
  • charged particle equilibrium
    ÇÏÀü(´ëÀü)ÀÔÀÚÆòÇü
  • colloid equilibrium
    ÄÝ·ÎÀ̵åÆòÇü(¡­øÁû¬).
  • dialysis, equilibrium
    ÆòÇüÅõ¼®
  • driven equilibrium Fourier transform sequence
    ÃßÁø ÆòÇü Fourier º¯È¯ ¿¬¼â
  • dynamic equilibrium
    µ¿ÀûÆòÇü(ÔÑîÜøÁû¬).
  • electrochemical equilibrium
    Àü±âÈ­ÇÐÀû(ï³Ñ¨ûùùÊîÜ) ÆòÇü(øÁû¬)
  • electron equilibrium
    ÀüÀÚÆòÇü
  • equilibrium
    ÆòÇü(øÁû¬)(»óÅÂ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • boundary sedimentation
    °æ°èħ°­(ÌÑÍ£öØË½)
  • differential sedimentation coefficient
    ºÐº° ħ°­°è¼ö(ÝÂܬöØË½Ìõâ¦)
  • droplet sedimentation
    ¾×Àû ħ°­(äûîÙöØË½)
  • isokinetic sedimentation
    µî¿ªÇРħÀü(ÔõÕôùÊöØîþ)
  • sedimentation
    ħ°­(öØË½)
  • sedimentation coefficient
    ħ°­°è¼ö(öØË½Ìõâ¦)
  • sedimentation field flow fractionation
    ħ°­Àå(öØË½íÞ) È帧ºÐȹ¹ý(ÝÂüñÛö)
  • sedimentation partition chromatography
    ħ°­ºÐ¹è(öØË½ÝÂÛÕ) Å©·Î¸¶Åä±×·¡ÇÇ
  • sedimentation potential
    ħ°­Àü¾Ð (öØË½ï³äâ)
  • sedimentation velocity
    ħ°­¼Óµµ(öØË½áÜÓø)
  • standard sedimentation coefficient
    Ç¥ÁØ Ä§°­°è¼ö(øöñÞöØË½Ìõâ¦)
  • streamer sedimentation
    È帧 ħÀü (öØîþ)
  • buoyant density
    ºÎÀ¯¹Ðµµ(Ý©ë´ÚËÓø)
  • charge density
    ÀüÇϹеµ(ï³ùÃÚËÓø)
  • density
    ¹Ðµµ(ÚËÓø)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • linear density
    ¼±»óÀ½¿µ
  • magnetic flux density
    ÀÚ±âÀ¯µ¿¹Ðµµ
  • middle density
    Áß°£À½¿µ, Áß°£¹Ðµµ
  • nodular density
    °áÀý¼ºÀ½¿µ
  • perihilar density
    Æó¹®ÁÖÀ§À½¿µ
  • pixel density
    Çȼ¿À½¿µ, È­¼ÒÀ½¿µ
  • proton (spin) density
    ¾çÀڹеµ
  • proton density contrast
    ¾çÀڹеµ´ëÁ¶
  • proton density weighted image
    ¾çÀڹеµ°­Á¶¿µ»ó
  • proton density weighting
    ¾çÀÚ°­Á¶
  • reticular density
    ¸Á»óÀ½¿µ
  • shadow density
    À½¿µ¹Ðµµ
  • spin density
    ½ºÇɹеµ
  • spin density weighted image
    ½ºÇɹеµ°­Á¶¿µ»ó
  • active gradient shielding
    ´Éµ¿°æ»çÂ÷Æó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ESR Erythrocyte Sedimentation Rate; 0 - 30 mm/Hr(¿µ¾Æ)
Sed. Rate Sedimentation Rate; ħ°­ ¼Óµµ
  = SR
SER   1) Smooth Endoplasmic Reticulum
  2) Sedimentation Erythrocyte Rate
&nbs...
SR   1) Sinus Rhythm
  2) Sedimentation Rate; ħ°­ ¼Óµµ
    =...
BSR basal skin resistance; blood sedimentation rate; bowel sounds regular; brain stimulation reinforceme...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ERNA Equilibrium radionuclide angiography
HWE Hardy-Weinberg Equilibrium
OEC Oxygen equilibrium curves
ENa equilibrium potential
E(K) equilibrium potential for K
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • free equilibrium
    ÀÚÀ¯ ÆòÇü
  • homeostatic equilibrium
    Ç×»ó¼º ÆòÇü
  • unstable equilibrium
    ºÒ¾ÈÁ¤ ÆòÇü
  • water equilibrium
    ¼öºÐ ÆòÇü
  • active gradient shielding
    ´Éµ¿ °æ»çÂ÷Æó
  • alveolar arterial oxygen gradient
    ÆóÆ÷µ¿¸Æ°£ »ê¼Ò ºÐ¾ÐÂ÷
  • alveolar O2 pressure gradient
    ÆóÆ÷ ³» »ê¼Ò ºÐ¾ÐÂ÷
  • concentration gradient
    ³óµµ °æ»ç
  • edge gradient
    °è¸é °æ»ç, °è¸é °æ»çµµ
  • fast gradient recalled echo method
    °í¼Ó °æ»ç ȸº¹ ¿¡ÄÚ ±â¹ý
  • fast multiplanar spoiled gradient recalled sequence
    °í¼Ó ´Ù¸é ȸ¼Õ °æ»ç ȸº¹ ¿¬¼â
  • flow compensation gradient technique
    À¯µ¿ º¸»ó °æ»ç ±â¹ý
  • frequency encoding gradient
    ÁÖÆÄ ¼ö ºÎȣȭ °æ»ç
  • magnetic field gradient
    ÀÚÀå °æ»ç
  • maximum gradient strength
    ÃÖ´ë °æ»ç °­µµ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
radioactive equilibrium <radiobiology> That condition in which the activities of the members of a radioactive chain decrease exponentially in time with the half-life of the chain precursor. Such radioactive equilibrium is only possible when the half-life of the precursor is longer than that of any other chain member. If the precursor half-life is so long that the change in the precursor population during the period of interest can be ignored, all the activities become sensibly equal and the equilibrium is said to be secular, otherwise it is said to be transient.
(16 Dec 1997)
magnetic field gradient In magnetic resonance imaging, a magnetic field that varies with location, superimposed on the uniform field of the magnet, to alter the resonant frequency of nuclei and allow recovery of their spatial position.
Synonym: field gradient.
(05 Mar 2000)
random mating equilibrium <genetics> In a population containing the genotypes of AA, aa, and Aa, the frequency of AA will be p2, the frequency of aa will be q2, and the frequency of Aa will be 2 pq at equilibrium, where p is the frequency of A and q is the frequency of a.
By the Hardy-Weinberg law, a ramdonly-mating population will eventually reach these frequencies and be at this equilibrium as long as there are no selection pressures on the population.
(09 Oct 1997)
genetic equilibrium A condition in which the rate of an allele's forward mutation is cancelled out by its rate of reverse mutation.
(09 Oct 1997)
ventricular gradient The algebraic sum of (i.e., the net electrical difference between) the area enclosed within the QRS complex and that within the T wave in the electrocardiogram.
(05 Mar 2000)
Gibbs-Donnan equilibrium An equilibrium established between a charged, immobile colloid (such as clay, ion exchange resin or cytoplasm) and a solution of electrolyte.
Characteristics: ions of like charge to the colloid tend to be excluded, ions of opposite charge tend to be attracted, the colloid compartment is electrically polarized relative to the solution in the same direction as the colloid charges (a Donnan potential) and the osmotic pressure is higher in the colloid compartment.
(18 Nov 1997)
voltage gradient <physiology> Literally, the electric field in a region, defined as the potential difference between two points divided by the distance between them. Used more loosely, the potential difference across a plasma membrane.
(18 Nov 1997)
cesium chloride gradient centrifugation A type of density gradient centrifugation, a lab technique used to separate or purify nucleic acids. It involves putting cesium chloride and the nucleic acids into a centrifuge to be spun for hours or days. The cesium chloride forms a density gradient (highly dense at the bottom, thinnest at the top), and the different nucleic acids separate along the gradient according to their buoyancies in different densities.
(09 Oct 1997)
gradient <physics> Mathematical term for the operator which determines the magnitude and direction of the greatest rate-of-change of a given function with position. Similarly used to describe such a rate-of-change.
For instance, at a given point on a hill, the slope of the hill in the steepest uphill direction is the gradient of the altitude function for the hill.
(09 Oct 1997)
gradient elution Elution in column chromatography in which a changing pH or ionic strength is used to separate substances.
(05 Mar 2000)
gradient encoding In magnetic resonance imaging, the technique of inducing a gradient in the magnetic field in the Y-axis to induce phase differences with location.
Synonym: gradient encoding.
(05 Mar 2000)
gradient perception <cell biology> Problem faced by a cell that is to respond directionally to a gradient of, for example: a diffusible attractant chemical.
In a spatial mechanism the cell would compare receptor occupancy at different sites on the cell surface, a temporal mechanism would involve comparison of concentrations at different times, the cell moving randomly between readings.
In pseudospatial sensing, the cell would detect the gradient as a consequence of positive feedback to protrusive activity if receptor occupancy increased with time as the protrusion moved up gradient. Few cell types have been unambiguously shown to detect gradients.
(18 Nov 1997)
chemical equilibrium <chemistry> A state in a reversible chemical reaction at which the reactants are turning into products at the same rate as the products are turning back into the reactants, so that the amounts of each reactant and product remains constant.
(09 Oct 1997)
mitral gradient The diastolic pressure difference between the left atrium and left ventricle.
(05 Mar 2000)
physiologic equilibrium nutritive equilibrium
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á